News
-
-
PRESS RELEASE
aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region
aap Implantate AG reports stable business development in Q1 2025, with significant sales growth in the EMEA region and successful new product placements. The company anticipates further growth in Q2 -
-
PRESS RELEASE
EQS-Adhoc: aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024
aap Implantate AG postpones the publication of its 2024 annual and consolidated financial statements due to auditor delay and resource constraints. New deadline set for June 2025 -
-
-
-
-
-
PRESS RELEASE
Significant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2 million (+6%)
aap Implantate AG reports 6% annual sales growth, reaching EUR 12.2 million in 2024. Progress in all regions except the USA, with investments in new aap systems for future growth